Jerry Foss
@jerrydf.bsky.social
Visiting fellow at Birmingham City University. Retired senior lecturer, Broadcast Engineering; 30 years Teleco R&D. Research interests in smart contracts, object media, personalisation, low latency
Yes. Mostly in favour - great for preventative care and personalised medicine. But I suspect the privacy is a main concern, especially when insurance companies buy into the data and determine your prsonalised premium, or even an "uninsurable" status. It's a two-edged pee-stick.
July 3, 2025 at 8:58 AM
Yes. Mostly in favour - great for preventative care and personalised medicine. But I suspect the privacy is a main concern, especially when insurance companies buy into the data and determine your prsonalised premium, or even an "uninsurable" status. It's a two-edged pee-stick.
I wonder how it performs in other medical applications
May 31, 2025 at 10:37 PM
I wonder how it performs in other medical applications